These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 1528304

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antiproliferative effects of mitoxantrone in ADR-sensitive and ADR-resistant P388 leukemia cells enhanced by vitamin K3.
    Parekh H, Chavan S, Chitnis M.
    Tumori; 1991 Dec 31; 77(6):484-90. PubMed ID: 1803714
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential effect of collaterally sensitive antimetabolites on P388 murine leukemia sensitive and resistant to adriamycin in vitro.
    Satyamoorthy K, Deshpande SS, Chitnis MP.
    Neoplasma; 1989 Dec 31; 36(6):673-83. PubMed ID: 2515459
    [Abstract] [Full Text] [Related]

  • 7. Circumvention of adriamycin resistance: effect of 2-methyl-1,4-naphthoquinone (vitamin K3) on drug cytotoxicity in sensitive and MDR P388 leukemia cells.
    Parekh HK, Mansuri-Torshizi H, Srivastava TS, Chitnis MP.
    Cancer Lett; 1992 Jan 10; 61(2):147-56. PubMed ID: 1730138
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.
    Johnson RK, Chitnis MP, Embrey WM, Gregory EB.
    Cancer Treat Rep; 1978 Oct 10; 62(10):1535-47. PubMed ID: 709555
    [Abstract] [Full Text] [Related]

  • 12. Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells by dipyrone.
    Chitnis MP, Kamath NS.
    Oncology; 1987 Oct 10; 44(1):47-50. PubMed ID: 3561929
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aclarubicin inhibits etoposide induced apoptosis through inhibition of RNA synthesis in P388 murine leukemic cells.
    Nagata T, Higashigawa M, Shimono Y, Cao DC, Yan Mao X, M'soka T, Inamochi H, Hori H, Kawasaki H, Sakurai M.
    J Exp Clin Cancer Res; 1998 Dec 10; 17(4):435-42. PubMed ID: 10089064
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Biochemical parameters of resistance of an adriamycin-resistant subline of P388 leukemia to emetine, an inhibitor of protein synthesis.
    Chitnis MP, Johnson RK.
    J Natl Cancer Inst; 1978 May 10; 60(5):1049-54. PubMed ID: 642026
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
    Ganapathi R, Reiter W, Krishan A.
    J Natl Cancer Inst; 1982 Jun 10; 68(6):1027-32. PubMed ID: 6953267
    [Abstract] [Full Text] [Related]

  • 20. Differential effect of clofibrate on adriamycin cytotoxicity in P388 murine leukemia cells sensitive and resistant to adriamycin.
    Chitnis M, Parekh H, Satyamoorthy K.
    Tumori; 1989 Apr 30; 75(2):100-5. PubMed ID: 2741213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.